Search
forLearn
5 / 801 resultslearn microbiota modulator
learn PTD-DBM
learn TDM-105795
learn APISCALP™
Research
5 / 1000+ results
research Beyond Perceived Stress: Hair Cortisol is linked with Cognition and Fatigue in Black and White Patients with Multiple Sclerosis
Higher cortisol levels and stress are linked to worse cognition and more fatigue in MS patients.
research The dark art of light measurement: accurate radiometry for low-level light therapy
Most low-level light therapy studies did not accurately report how light was measured, affecting treatment reliability.
research The Inflammatory Caspases-1 and -11 Mediate the Pathogenesis of Dermatitis in Sharpin-Deficient Mice
Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.
research The new paradigm for androgenetic alopecia and plant-based folk remedies: 5α-reductase inhibition, reversal of secondary microinflammation and improving insulin resistance
Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.
research Antagonism of NMDA receptors as a potential treatment for Down syndrome: a pilot randomized controlled trial
Memantine may slightly improve memory in people with Down syndrome, but more research is needed.
Community Join
5 / 1000+ resultscommunity Following the recent IPO and the positive Phase 3 clinical data for VDPHL01 (extended-release oral minoxidil), what is the projected timeline for the FDA submission and the subsequent commercial availability on the market?
Veradermics' extended-release oral minoxidil is expected to be commercially available in 2027-2028, while another company, Minx, may release a similar product sooner. VDPHL01 is considered more clinically validated compared to Minx.
community Pelage receiving over $100 million from investors doesn't always equal success.
Pelage received $120 million for phase 3 of PP405, a potential hair loss treatment, but there is skepticism about its success. Some users believe any improvement over finasteride is a win, while others expect full hair regrowth.
community (42M) 6 years Fin > Dut > Dut + Oral Min
A 42-year-old man used finasteride for three years, switched to dutasteride, and added oral minoxidil, resulting in stabilized hair loss and some regrowth, especially with dutasteride. He experienced no side effects and plans to consider a hair transplant in the future.
community Why didn’t Justin Bieber boof his finasteride
Justin Bieber's hair loss and his choice not to use finasteride or other treatments like rectal injection are discussed, with reasons speculated to be side effects or lack of concern. The conversation also mentions his past hair transplant and suggests his wealth and fame might make appearance less of a priority.
community 4 months on oral finasteride and oral minoxidil for
A 25-year-old user shared progress pictures after using oral finasteride and oral minoxidil for nearly four months, reporting significant crown gains and slight temple progress without side effects. The user chews a Hims 3-in-1 tablet and has not experienced any shedding due to starting with a shaved head.